
Health Care · NSE / BSE
Sudeep Pharma Limited, incorporated in 1989, is a global manufacturer of pharmaceutical excipients, food-grade minerals, and specialty nutrition ingredients, supplying over 200 products to customers in more than 100 countries. The company operates six manufacturing facilities with a total capacity of 50,000 MT, producing key minerals such as calcium, iron, magnesium, zinc, potassium, and sodium. With strong in-house R&D and pilot-scale labs, the company focuses on developing high-quality mineral salts and excipients across its pharmaceutical, food and nutrition, specialty ingredients, and triturates product segments. As of December 31, 2024, it employed 704 permanent staff.
Price Band
₹563 – ₹593
Issue Size
₹895 Cr
Lot Size
25 shares
GMP
+15.8%
Est. Listing
₹687
at current GMP
Subscribed
93.72x
overall
Open
21 Nov 2025
Close
25 Nov 2025
Allotment
26 Nov 2025
Refund
27 Nov 2025
Demat Credit
28 Nov 2025
Listing
28 Nov 2025
Last updated: 19 Oct 2026
Current Premium
Issue Price (Upper)
₹593
Band: ₹563 – ₹593
Estimated Listing Price
₹687
Upper price + GMP
Lot Size
25 shares
Min investment ₹14,825
Estimated Profit / Lot
₹2,350
25 × ₹94
Grey Market Premium trend
+₹94
▲ 0 today
Updated less than a minute ago
| Date | GMP (₹) | GMP % | Est. Listing |
|---|---|---|---|
| 31 Oct 2026 | +₹94 | 15.8% | ₹687 |
| 30 Oct 2026 | +₹94 | 15.8% | ₹687 |
| 29 Oct 2026 | +₹85 | 14.3% | ₹678 |
GMP is unofficial market data. Not a guarantee of listing performance.
Sudeep Pharma Limited is bringing an initial public offering (IPO) in the Health Care sector with an aggregate issue size of ₹895 Crores. The shares are offered at a price band of ₹563 to ₹593 per equity share on NSE and BSE. Currently, market analysts recommend evaluating the company's financial valuation, price-to-earnings (P/E) multiple, and peer comparison prior to submitting bids.
The public offer consists of a fresh issue and offer-for-sale structured under SEBI regulations. Bidding is open to Qualified Institutional Buyers (QIB), Non-Institutional Bidders (NII/HNI), and Retail Individual Investors (RII). Applications can be submitted online using ASBA or UPI mandate through certified stock brokers and net banking portals.
Following the close of bidding on 2025-11-25, the basis of allotment is scheduled to be finalized on 2025-11-26. Investors can verify their application status online by submitting their PAN card number, Application Number, or DP Client ID on the registrar's official portal (Link Intime India Private Limited) or the BSE allotment checking window.
The latest grey market premium for Sudeep Pharma Limited IPO is ₹94, which indicates an expected listing price of ₹687.
Kostak rate is the profit amount an investor earns by selling their entire IPO application in the grey market before allotment is finalized.
No. GMP is an unofficial indicator discovered between dealers outside of SEBI-regulated exchanges. Actual listing price is determined by demand-supply discovery on NSE/BSE during the pre-open auction.